Skip to main content

Vetera GoldXP (Canada)

This page contains information on Vetera GoldXP for veterinary use.
The information provided typically includes the following:
  • Vetera GoldXP Indications
  • Warnings and cautions for Vetera GoldXP
  • Direction and dosage information for Vetera GoldXP

Vetera GoldXP

This treatment applies to the following species:
Company: Boehringer Ingelheim Animal Health

Encephalomyelitis-Rhinopneumonitis-Influenza-West Nile Virus Vaccine

Eastern & Western, Killed Virus

Tetanus Toxoid

Vetera GoldXP Indications

This product has been shown to be effective for the vaccination of healthy horses 4 months of age or older, including pregnant mares, against eastern and western encephalomyelitis (EEE & WEE), west nile virus (WNV), and tetanus; and against respiratory disease due to equine herpesvirus types 1 and 4 (EHV-1 & EHV-4) and A2 equine influenza virus (EIV). The duration of immunity against EIV OH/03 is at least 6 months and against WNV is at least 12 months. The duration for the remaining organisms has not been determined. For more information regarding efficacy and safety data go to productdata.aphis.usda.gov.

This product has also been shown to be effective against shedding due to A2 EIV and against viremia, mortality, and neurologic clinical disease due to WNV.

Composition

Contains Kentucky Lineage (KY/95), Florida sublineage clade 1 (OH/03), and Florida sublineage clade 2 (RI/07) EIV strains. Amphotericin B and gentamicin added as preservatives.

Directions and dosage: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1mL dose. Administer a second 1 mL dose intramuscularly in 3 to 4 weeks using a different injection site. Historically, annual revaccination with this product has been recommended. The need for annual booster vaccination has not been established for this product. For advice on revaccination frequency, contact your veterinarian or the manufacturer.

Precautions

Store at 2-8°C. Do not freeze. Do not mix with other products. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician.

For use in animals only.

Manufactured by:

Boehringer Ingelheim Animal Health USA Inc., St. Joseph, MO 64506

Tel: 1 (888) 637-4251

VLN/PCN 124/4855.25

Distributed by:

Boehringer Ingelheim Animal Health Canada Inc., Burlington ON L7L 5H4

Vetera® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH. Used under license.

1 dose/1 mL

137108-04

10 doses/10 mL

137107-04

CPN: 1182198.0

BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
5180 SOUTH SERVICE ROAD, BURLINGTON, ON, L7L 5H4
Customer Care No.:   1-800-567-1885
Technical Services No.:   1-877-565-5501
Website:   www.boehringer-ingelheim.ca
THIS SERVICE AND DATA ARE PROVIDED "AS IS". Animalytix assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the Animalytix service and data. See the Terms of Use for further details.

Copyright © 2024 Animalytix LLC. Updated: 2024-02-27